| Document And Entity Information | Mar. 11, 2021 |
| Document Information Line Items | |
| Entity Registrant Name | Fuse Group Holding Inc. |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Amendment Description | Fuse Group Holding Inc. (the “Company”) is filing this Amendment No. 1 (this “Amendment”) to amend its Current Report on Form 8-K, initially filed with the Securities and Exchange Commission on March 17, 2021 (the “Original 8-K”). The purpose of this Amendment is to expand the disclosure to clarify that E-Mo Biotech Holding Inc. is a start-up, development-stage company involving in vaccine, immunological treatment and diagnostic product research and development and currently has no commercial sales of vaccines, treatments, or diagnostic products.
This Amendment reports events as of the filing date of the Original 8-K and does not reflect events that may have occurred subsequent to the original filing date, and except as described above, no other changes have been made to the Original 8-K. |
| Entity Central Index Key | 0001636051 |
| Document Period End Date | Mar. 11, 2021 |
| Entity Emerging Growth Company | true |
| Entity Ex Transition Period | false |
| Entity Incorporation, State or Country Code | NV |
| Entity File Number | 333-202948 |
| Entity Tax Identification Number | 47-1017473 |
| Entity Address, Address Line One | 805 W. Duarte Rd., Suite 102 |
| Entity Address, City or Town | Arcadia |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 91007 |
| City Area Code | (626) |
| Local Phone Number | 210-0000 |
| Written Communications | true |
| Soliciting Material | true |
| Pre-commencement Tender Offer | true |
| Pre-commencement Issuer Tender Offer | true |
| Title of 12(b) Security | None |
| No Trading Symbol Flag | true |
| Security Exchange Name | NONE |
